Middle ear infection in children is much more common than in adults, in part because of how this part of the ear is designed.

Emapalumab is approved for both adults and pediatric (newborn and older) patients with MAS in Still disease with an inadequate response or intolerance to glucocorticoids, or with recurrent MAS.

Ear Infection. Centers for Disease Control and Prevention. July 1, 2021. Sarrell EM, Cohen HA, Kahan E. Naturopathic Treatment for Ear Pain in Children. Pediatrics. May 2003. Ear Infection (Middle ...

Dear Dr. Roach: I am 90 years old and cannot sleep at night. I have tried taking two or three times the dosage of most ...

This approval marks the eighth disease indication for Dupixent as a new alternative for patients—many of whom are elderly and ...

DEAR DR. ROACH: I am 90 years old and cannot sleep at night. I have tried taking two or three times the dosage of most ...

Sobi® (STO: SOBI) today announced that the U.S. Food and Drug Administration (FDA) approved Gamifant® (emapalumab-lzsg) for the treatment of adult and pediatric (newborn and older) patients with ...

Other natural treatments for yeast infections. Here are some lifestyle tips that may help prevent or lessen yeast infections: Keep your vaginal area cool and dry. Avoid food high in sugar.

The FDA has approved Gamifant as the first-ever treatment for macrophage activation syndrome in Still’s disease for adults ...

The approval was supported by pooled data from 2 open-label, single arm trials: the phase 2 NI-0501-06 study and the phase 3 EMERALD trial.

Treatment with salanersen slowed neurodegeneration and improved motor function in children with SMA in a Phase 1 trial, ...

Stockholm, Sweden Monday, June 30, 2025, 10:00 Hrs [IST] ...